Hope for thousands as NHS approves drug for acute migraine
First and only Nice-recommended medicine could ‘alleviate misery’ of condition in England and WalesNHS health advisers have approved the first treatment foracute migraine in a decision that promises to bring relief to about 13,000 people.The National Institute of Health and Clinical Excellence (Nice) has recommended a drug called rimegepant, also known as Vydura, which is made by Pfizer.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Denis Campbell Health policy editor Tags: Health NHS Neuroscience UK news Society England Wales Source Type: news
More News: Brain | Headache | Migraine | National Institute for Health and Clinical Excelle | National Institutes of Health (NIH) | Neurology | Neuroscience | Pfizer | Science | Wales Health